Question $3$ Worth $10$ marks

This semester you valued CSL Limited using relative valuation and intrinsic valuation. The company has four segments: CSL Behring, CSL Seqirus, CSL Vifor and CSL Plasma. The segments focus on the research, manufacture and distribution of different pharmaceutical products.

Describe how you estimated CSL Limited$$s current cash flow for $2023.$ Your answer cannot be more than half an A$4$ page. $($Worth $3$ marks$)$

Describe how you estimated the growth rates in your intrinsic valuation of CSL Limited. In your answer you will need to explain why the approach you used to estimate the growth rates was the best approach to use. Your answer cannot be more than half an A$4$ page. $($Worth $3$ marks$)$

Describe two problems your group experienced whilst you were estimating the value of CSL Limited using relative valuation. In your answer, you will need to explain how your group overcame these problems to estimate the relative value of shares in CSL Limited. Your answer cannot be more than half an A$4$ page. $($Worth $2$ marks$)$

Explain how rivalry amongst companies in the same industry as CSL Limited and the threat of new entrants had an impact on the profitability of CSL Limited. $($Worth $2$ marks$)$